Cargando…

Experimental and Investigational Targeted Therapies for the Management of Fibrosis in NASH: An Update

There have been major advances in the treatment of HBV and HCV with anti-viral treatments, which is reducing the prevalence of fibrosis due to these viruses and obviating the need for anti-fibrotic therapies in these diseases. At the same time, however, the prevalence of non-alcoholic fatty liver di...

Descripción completa

Detalles Bibliográficos
Autores principales: Huisman, Tsipora M, Dieterich, Douglas T, Friedman, Scott L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987269/
https://www.ncbi.nlm.nih.gov/pubmed/33776490
http://dx.doi.org/10.2147/JEP.S265286